KLRK1 and cancer: Aberrant NKG2D expression in different human cancer types was evaluated in the TIMER 2.0 program by analysing the RNA sequence data from The Cancer Genome Atlas (TCGA) data (http://timer.cistrome.org/) (Fig. 1A).